RISEDRONATE SODIUM
These highlights do not include all the information needed to use RISEDRONATE SODIUM DELAYED-RELEASE TABLETS safely and effectively. See Full Prescribing Information for RISEDRONATE SODIUM DELAYED-RELEASE TABLETS.RISEDRONATE SODIUM delayed-release tablets, for oral useInitial U.S. Approval: 1998
1d9e520b-2fa6-4603-b397-f0fc24fae775
HUMAN PRESCRIPTION DRUG LABEL
Sep 9, 2020
Sun Pharmaceutical Industires Inc.
DUNS: 146974886
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
RISEDRONATE SODIUM
Product Details
FDA regulatory identification and product classification information